Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2 | P11137 | 2/20 | 0.43 |
| ▸ | GPR17 | Q13304 | 3/20 | 0.42 |
| ▸ | EIF4A3 | P38919 | 1/20 | 0.40 |
| ▸ | DAO | P14920 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.37 |
| ▸ | JAK2 | O60674 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31332568 | 0.88 | MAP2 (0.41) | MAP2GPR17DAOAR | |
| SCHEMBL31416433 | 0.87 | MAP2 (0.49) | MAP2GPR17EIF4A3AR | |
| SCHEMBL27397857 | 0.85 | DAO (0.42) | MAP2GPR17DAOAR | |
| SCHEMBL31171910 | 0.84 | EIF4A3 (0.43) | MAP2GPR17EIF4A3DAOJAK2 | |
| SCHEMBL19331084 | 0.84 | MEN1 (0.41) | MAP2GPR17DAOAR | |
| SCHEMBL8959566 | 0.80 | PRNP (0.48) | GPR17 | |
| SCHEMBL27805830 | 0.77 | GPR17 (0.58) | MAP2GPR17EIF4A3 | |
| SCHEMBL31332498 | 0.76 | PTGS2 (0.50) | — | |
| SCHEMBL22760181 | 0.75 | MAP2 (0.42) | MAP2 | |
| SCHEMBL31416150 | 0.75 | HRH4 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747234-A1 | KV1.3 POTASSIUM CHANNEL ANTAGONISTS | Muna Therapeutics ApS (DK) | 2026-05-27 | — | — | EP | disclosed |
| EP-4747235-A1 | KV1.3 POTASSIUM CHANNEL ANTAGONISTS | Muna Therapeutics ApS (DK) | 2026-05-27 | — | — | EP | disclosed |
| WO-2025017105-A1 | KV1.3 POTASSIUM CHANNEL ANTAGONISTS | MUNA THERAPEUTICS APS (DK) | 2025-01-23 | — | — | WO | disclosed |
| WO-2025017103-A1 | KV1.3 POTASSIUM CHANNEL ANTAGONISTS | MUNA THERAPEUTICS APS (DK) | 2025-01-23 | — | — | WO | disclosed |